A systematic review of the management of acute superior mesenteric vein thrombosis in adults

by Eimear Phoenix, MB BCh BAO, Jonathan Beck, MB BCh BAO, BSc, Timothy J. Patterson, MB BCh BAO, BSc, Robert A.J. Spence, MB BCh BAO, MEd, Mark A. Taylor, MB BCh BAO, PhD, Gary M. Spence, MB BCh BAO, MD
Published 2020-09-01

Alterations of chromosome 3p in 24 cases of gastrinomas and their correlations with clinicopathological and prognostic features

by Yuan-Jia Chen, MD, Jeremiah V. Ojeaburu, MD, Alexander Vortmeyer, MD, Shuang Yu, MD, Robert T. Jensen, MD
Published 2020-03-01

Surgical treatment of non-functioning pancreatic neuroendocrine tumors: current controversies and challenges

by Kelvin O. Memeh, MD, MRCS, Tanaz Vaghaiwalla, MD, Xavier M. Keutgen, MD, FACS
Published 2020-06-01

Serum biomarker CD163 predicts overall survival in patients with pancreatic ductal adenocarcinoma

by Qinglin Fei, MD, Yu Pan, MD, PhD, Xingxing Yu, MD, Ronggui Lin, MD, PhD, Xianchao Lin, MD, PhD, Heguagn Huang, MD
Published 2020-09-01

The Achilles’ Heel of Pancreatic Cancer: Targeting pancreatic cancer's unique immunologic characteristics and metabolic dependencies in clinical trials

by Despina Siolas, MD, PhD, Christy Morrissey, MD, Paul E. Oberstein, MD
Published 2020-09-01

Early drain removal after major pancreatectomy reduces postoperative complications: a single-center, randomized, controlled trial

by Menghua Dai, MD, Qiaofei Liu, MD, Cheng Xing, MD, Jorg Kleeff, MD, FACS, Quan Liao, MD, Junchao Guo, MD, Xianlin Han, MD, Qiang Xu, MD, Shunda Wang, MD
Published 2020-06-01

Decreased 68Ga-NOTA-exendin-4 renal uptake in patients pretreated with Gelofusine infusion: a randomized controlled study

by Yaping Luo, MD, Qingqing Pan, MD, Fang Li, MD
Published 2020-09-01

Adjuvant and neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma

by Carl S. Leonhardt, MD, Benno Traub, MD, Thilo Hackert, MD, Ulla Klaiber, MD, Oliver Strobel, MD, Markus W. Büchler, MD, John P. Neoptolemos, MA, MD, MB, BChir, FRCS, FMedSci
Published 2020-03-01

The role of radiation for pancreatic adenocarcinoma

by Adriana C. Gamboa, MD, Rachel M. Lee, MD, MSPH, Shishir K. Maithel, MD
Published 2020-06-01

Efficacy and toxicity comparison of nab-paclitaxel plus S-1 and nab-paclitaxel plus gemcitabine as first-line chemotherapy for metastatic pancreatic cancer

by Xi Guo, MD, Yaolin Xu, MD, Yuan Ji, MD, Yue Fan, MD, Dansong Wang, MD, Dayong Jin, MD, Rongyuan Zhuang, MD, Lili Wu, MD, Wenhui Lou, MD, Yuhong Zhou, MD
Published 2020-03-01

An overview of pancreatic trauma

by Harshit Agarwal, MS, MCh, Amit Gupta, MS, FRCS, Subodh Kumar, MS, FRCS
Published 2020-09-01

DUSP1 Blocks autophagy-dependent ferroptosis in pancreatic cancer

by Yangchun Xie, Feimei Kuang, Jiao Liu, Daolin Tang, MD, Rui Kang
Published 2020-09-01

Guidelines for the diagnosis and treatment of acute pancreatitis in China (2021)

by Fei Li, Shouwang Cai, Feng Cao, Rufu Chen, Deliang Fu, Chunlin Ge, Chunyi Hao, Jihui Hao, Heguang Huang, Zhixiang Jian, Gang Jin, Ang Li, Haimin Li, Shengping Li, Weiqin Li, Yixiong Li, Tingbo Liang, Xubao Liu, Wenhui Lou, Yi Miao, Yiping Mou, Chenghong Peng, Renyi Qin, Chenghao Shao, Bei Sun, Guang Tan, Xiaodong Tian, Huaizhi Wang, Lei Wang, Wei Wang, Weilin Wang, Junmin Wei, Heshui Wu, Wenming Wu, Zheng Wu, Changqing Yan, Yinmo Yang, Xiaoyu Yin, Xianjun Yu, Chunhui Yuan, Taiping Zhang, Yupei Zhao, on behalf of the Chinese Pancreatic Surgery Association
Published 2021-06-01

Implementation of an educational program for pancreaticoduodenectomy in a university hospital: a retrospective observational study

by Sohei Satoi, Tomohisa Yamamoto, So Yamaki, Satoshi Hirooka, Daisuke Hashimoto, Tatsuma Sakaguchi, Hironori Ryota, Rintaro Yui, Kazuto Sakuramoto, Hideyuki Matsushima, Hiroaki Yanagimoto, Hideyoshi Toyokawa, Taku Michiura, Kentaro Inoue, Mitsugu Sekimoto
Published 2021-06-01

Notch signaling inhibitor and anti-PD-L1 antibody combination therapies decelerate tumor progression in pancreatic cancer

by Hongmei Dai, Xiafei Hong, Dan Huang, Huanwen Wu, Xianze Wang, Hao Chen, Rui Jiang, Wenyan Chen, Yupei Zhao, Wenming Wu
Published 2021-06-01

Current situation, consensus and controversy of perioperative nutrition management in pancreatic surgery: A narrative review

by Jingyong Xu, Junmin Wei
Published 2021-03-01

An evaluation of treatments and survival rates for pancreatic adenocarcinoma through survival analysis with inverse probability of treatment weighting: a population-based study

by Suzhen Wang, Chen Wang, Fuyan Shi, Enxue Tao, Gaopei Zhu, Juan Li, Jianing Feng, Xiaoxuan Wang, Jing Guo, Qingfeng Zheng, Bo Zhang
Published 2021-03-01

Metastatic well-differentiated pancreatic neuroendocrine tumors to the liver: a narrative review of systemic and surgical management

by Tanaz Vaghaiwalla, Kelvin Memeh, Chih-Yi Liao, Xavier M. Keutgen
Published 2021-06-01

Roles of FGF21 and irisin in obesity-related diabetes and pancreatic diseases

by Ting Xie, PhD, Po Sing Leung, PhD
Published 2020-03-01

A contemporary evidence basis for neoadjuvant chemotherapy in upfront resectable pancreatic adenocarcinoma: a systematic review of the literature

by David P. Stonko, MD, MS, Jin He, MD, PhD, Lei Zheng, MD, PhD, Alex B. Blair, MD
Published 2020-03-01